Australia markets closed

Avicanna Inc. (AVCNF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.45790.0000 (0.00%)
At close: 12:50PM EST
Full screen
Trade prices are not sourced from all markets
Previous close0.4579
Open0.4579
BidN/A x N/A
AskN/A x N/A
Day's range0.4579 - 0.4579
52-week range0.4180 - 1.2640
Volume85
Avg. volume6,830
Market cap20.999M
Beta (5Y monthly)2.18
PE ratio (TTM)N/A
EPS (TTM)-0.4840
Earnings date12 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Avicanna Enters Master Supply Agreement with Chilean Pharmaceutical Pioneer Knop Laboratorios S.A.

    Knop Laboratorios Knop Laboratorios Expansion and fortification of relationship since 2020 with established pharmaceutical company in Chile Supply of Avicanna’s active pharmaceutical ingredients for existing commercial and pipeline of pharmaceutical products in South America TORONTO, Jan. 14, 2022 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of pla

  • GlobeNewswire

    Avicanna Announces the Appointment of Stephen Kim as Chief Legal Officer & General Counsel

    TORONTO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Avicanna USA Inc. together with Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of organic and sustainable plant-derived cannabinoid-based products, is pleased to announce the appointment of Stephen Kim as the Avicanna’s Chief Legal Officer & General Counsel. Mr. Kim comes with over twenty years of legal experience with highly

  • GlobeNewswire

    Avicanna Announces Changes to its Board of Directors

    TORONTO, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce the appointment of Eileen McCormack to, and the resignation of Setu Purohit from, its board of directors effective immediately. Eileen McCormack is an experienced senior marketing executive with more than 30 years